COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms 11/15/2022 mRNA COVID-19 vaccines did not increase the type, frequency, or severity of immune-related side effects among people taking immune checkpoint inhibitors to treat cancer, a study at Memorial Sloan Kettering Cancer Center found. CDC and other medical groups generally recommend that people with cancer receive an mRNA COVID-19 vaccine. You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892